Johnson & Johnson has to pay $8 billion after male breast growth linked to antipsychotic drug, jury says

Johnson & Johnson will have to pay $8 billion in punitive damages after a man claims the company didn’t warn young men that the drug Risperdal could grow breasts, a jury said Tuesday, according to Reuters.